His main research concerns Microbiology, Antibacterial agent, Mutant, DNA gyrase and Bacteria. As part of his studies on Microbiology, Xilin Zhao often connects relevant areas like Biochemistry. His study in Antibacterial agent is interdisciplinary in nature, drawing from both In vitro and Programmed cell death.
His Mutant study incorporates themes from Ciprofloxacin, Minimum inhibitory concentration, Drug resistance and Mycobacterium tuberculosis. Particularly relevant to Topoisomerase IV is his body of work in DNA gyrase. His Topoisomerase IV research includes elements of Molecular biology, Topoisomerase and Quinolone.
Microbiology, Reactive oxygen species, Antibacterial agent, Antimicrobial and Mutant are his primary areas of study. His research integrates issues of Staphylococcus aureus, Bacteria and Escherichia coli in his study of Microbiology. His Reactive oxygen species research incorporates themes from Oxolinic acid, Programmed cell death, Intracellular and Hydroxyl radical.
His Antibacterial agent study combines topics in areas such as Ciprofloxacin, DNA gyrase, Levofloxacin, Chloramphenicol and Drug resistance. His work deals with themes such as Mycobacterium smegmatis, Topoisomerase, Topoisomerase-II Inhibitor and Quinolone, which intersect with DNA gyrase. His studies deal with areas such as Lethality and Antioxidant as well as Antimicrobial.
The scientist’s investigation covers issues in Microbiology, Reactive oxygen species, Antimicrobial, Escherichia coli and Bacteria. His research brings together the fields of Staphylococcus aureus and Microbiology. His Reactive oxygen species research is multidisciplinary, incorporating perspectives in Catalase, Oxolinic acid, Intracellular, Programmed cell death and Thymineless death.
His biological study spans a wide range of topics, including Kanamycin, Antibiotics, Antibiotic resistance, Antioxidant and Methicillin resistance. His Escherichia coli research incorporates themes from Mutant, Chloramphenicol and Topoisomerase-II Inhibitor. His Bacteria study which covers Quinolone that intersects with Amino acid, Topoisomerase IV and DNA gyrase.
Xilin Zhao mostly deals with Reactive oxygen species, Microbiology, Antimicrobial, Programmed cell death and Antioxidant. The Ampicillin research he does as part of his general Microbiology study is frequently linked to other disciplines of science, such as Superoxide, therefore creating a link between diverse domains of science. Superoxide is intertwined with Resveratrol, Oxolinic acid and Antibiotics in his study.
Much of his study explores Antioxidant relationship to Kanamycin. His Lethality research integrates issues from Catalase, Antibiotic resistance, Toxicity and Bacterial cell structure. His DNA research is multidisciplinary, incorporating perspectives in Intracellular, Cell biology and Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Karl Drlica;Xilin Zhao.
Microbiology and Molecular Biology Reviews (1997)
Quinolone-mediated bacterial death.
Karl Drlica;Muhammad Malik;Robert J. Kerns;Xilin Zhao.
Antimicrobial Agents and Chemotherapy (2008)
Restricting the Selection of Antibiotic-Resistant Mutants: A General Strategy Derived from Fluoroquinolone Studies
Xilin Zhao;Karl Drlica.
Clinical Infectious Diseases (2001)
Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae
Joseph M. Blondeau;Xilin Zhao;Glen Hansen;Karl Drlica.
Antimicrobial Agents and Chemotherapy (2001)
Mutant selection window hypothesis updated.
Karl Drlica;Xilin Zhao.
Clinical Infectious Diseases (2007)
Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus.
Yuzhi Dong;Xilin Zhao;John Domagala;Karl Drlica.
Antimicrobial Agents and Chemotherapy (1999)
Quinolones: Action and Resistance Updated
Karl Drlica;Hiroshi Hiasa;Robert Kerns;Muhammad Malik.
Current Topics in Medicinal Chemistry (2009)
Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window.
Xilin Zhao;Karl Drlica.
The Journal of Infectious Diseases (2002)
DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Xilin Zhao;Chen Xu;John Domagala;Karl Drlica.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Contribution of Oxidative Damage to Antimicrobial Lethality
Xiuhong Wang;Xilin Zhao.
Antimicrobial Agents and Chemotherapy (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: